Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “MacRegen, Inc.”

2 pharma patents match "MacRegen, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 2 pharmaceutical patents matching "MacRegen, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2 results for “MacRegen, Inc.” · 30,257 patents in full index Clear search

  1. US 10905770

    Topical delivery of therapeutic agents using cell-penetrating peptides for the treatment of age-related macular degeneration and other eye diseases

    MacRegen, Inc. · Granted Feb 2, 2021 · Expires Jan 28, 2041

    granted
  2. US 10426817

    Treatment of age-related macular degeneration and other eye diseases with apolipoprotein mimetics

    MacRegen, Inc. · Granted Oct 1, 2019 · Expires Sep 26, 2039

    granted